Mirum Pharmaceuticals (MIRM) Current Assets (2018 - 2026)

Mirum Pharmaceuticals has reported Current Assets for 9 years, with the latest figure at $569.4 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 38.61% year-over-year to $569.4 million; the trailing twelve-month figure through Mar 2026 stood at $569.4 million (up 38.61% YoY), and the FY2025 full-year result was $549.7 million, up 39.94% from the prior year.
• Current Assets for Q1 2026 stood at $569.4 million, up from $549.7 million in the prior quarter.
• The five-year high for Current Assets was $569.4 million in Q1 2026, with the low at $147.2 million in Q2 2022.
• Average Current Assets over 5 years is $358.3 million, with a median of $387.5 million recorded in 2023.
• Year-over-year, Current Assets plunged 35.52% in 2022 and surged 160.46% in 2023.
• Tracing MIRM's Current Assets over 5 years: stood at $190.2 million in 2022, then soared by 103.73% to $387.5 million in 2023, then gained by 1.35% to $392.8 million in 2024, then surged by 39.94% to $549.7 million in 2025, then gained by 3.59% to $569.4 million in 2026.
• The last three Current Assets figures came in at $569.4 million (Q1 2026), $549.7 million (Q4 2025), and $530.6 million (Q3 2025), per Business Quant data.

Peer Comparison